Research Library

The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.

The House recently passed the Tax Relief for American Families and Workers Act (TRAFWA) of 2024, which aims to provide tax relief to businesses and families with children in a fiscally responsible manner. But, as fellow John W. Diamond’s new commentary explains, if the bill succeeds, it would instead deliver more reckless tax giveaways while further delaying a real effort to deal with the consequences of poor fiscal policy.

Legislative action on the ballooning federal deficit is long overdue. Fellow John W. Diamond proposes a new nonpartisan fiscal commission to bypass congressional inaction on reform.

For research involving human embryos and other controversial subjects, science journals should require ethics statements from researchers detailing research oversight, what embryos were used, how many and for how long. This will help increase transparency and improve communication with the public, writes Science and Technology Policy Fellow Kirstin R.W. Matthews.

In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.

Convening war rooms, planning speedy bailouts and raising "house-on-fire" alarm bells: Those are a few of the ways the biggest banks and financial regulators are preparing for a potential default on U.S. debt.

Texas lawmakers must address the misuse of anticipation notes — short-term debt securities used to raise money for public projects, writes John Diamond, the Edward A. and Hermena Hancock Kelly Fellow in Public Finance. Since they don’t require voter approval, politicians could use them to fund unwanted projects, he explains.

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.